key: cord-0739281-7uird61o
authors: Mendoza, M; Garcia‐Ruiz, I; Carreras, E; Suy, A
title: Authors' reply re: Pre‐eclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study
date: 2020-11-23
journal: BJOG
DOI: 10.1111/1471-0528.16583
sha: 0c5c062c25b81ab1e01d4406ac3aca75ce3465e7
doc_id: 739281
cord_uid: 7uird61o

nan

Thank you for the opportunity to respond to the letter from Leavitt and colleagues. 1 We would like to thank them for their interest in our study 2 and their valuable observations. We agree with Leavitt and colleagues that a similar underlying pathophysiology (endothelial damage) may exist in both pre-eclampsia (PE) and COVID-19, which may explain most of their common clinical manifestations.

Other authors have suggested that the signs and symptoms of PE present in some pregnant women with COVID-19 could be a consequence of the placental dysfunction due to intravascular inflammation associated with the infection, leading to a prothrombotic state in the placenta. 3 This hypothesis is supported by the higher rates of maternal vascular malperfusion features observed from placentas of women with COVID-19. 4 Although this hypothesis has biological plausibility, previous studies have shown a correlation between placental histological findings consistent with maternal underperfusion and anti-angiogenic status. 5 By contrast, in our study we did not find increased soluble fms-like tyrosine kinase-1/placental growth factor values in most of the women with COVID-19 and signs and symptoms of PE. For this reason, we believe that the placental malperfusion due to COVID-19 is unlikely to be the main aetiology of the PE-like syndrome.

Thus, we agree with Leavitt and colleagues that the shared pathophysiology between COVID-19 and PE is probably related to immunothrombosis and decreased alpha-1-antitrypsin (AAT) and that further research is needed to better understand the causes of PE and PE-like syndrome in order to achieve appropriate treatments for these conditions. & 

Re: Pre-eclampsialike syndrome induced by severe COVID-19: a prospective observational study

Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study

Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection?

Placental Pathology in COVID-19

Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion